📰 Inhibitor Program News
Page 2 - Inhibitor Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Inhibitor Program. Real-time updates on events, politics, business and more.
April 18, 2023
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 18, 2023 -- ORIC Pharmaceuticals, Inc. , a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic... | April 18, 2023
August 8, 2022
08.08.2022 - - Positive interim data from barzolvolimab Phase 1b Study in Chronic Spontaneous Urticaria presented at EAACI 2022 - - First patients dosed in Phase 2 chronic urticaria studies - HAMPTON, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) - Celldex ...
July 11, 2022
KalVista Pharmaceuticals Presents New Data for Sebetralstat and its Oral Factor XIIa Inhibitor Program
April 12, 2022
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 12, 2022 -- ORIC Pharmaceuticals, Inc. , a clinical stage oncology company focused on developing treatments that address mechanisms of... | April 12, 2022
February 24, 2022
Kronos Bio, Inc. , a company dedicated to transforming the lives of those affected by cancer and other serious diseases, today reported recent business progress and fourth-quarter and full-year 2021... | February 24, 2022
December 30, 2021
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a Phase 2 clinical trial evaluating the...
December 30, 2021
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a Phase 2 clinical trial evaluating the...
December 30, 2021
U.S. FDA granted JZP150 Fast Track designation in PTSD, underscoring the unmet needs of patients If approved, JZP150 would become the first new drug approved in 20 years for patients